Investment Considerations Telomir Pharmaceuticals is pioneering the development of Telomir-1, a novel small molecule with the potential to address the root causes of aging and age-related conditions by lengthening telomeres, positioning the company at the forefront of the emerging longevity market. The company’s dual focus on human and veterinary applications for Telomir-1 provides a diversified … Continue reading “Telomir Pharmaceuticals Inc. (NASDAQ: TELO)”
Symbol | Release | Time | Source |
---|---|---|---|
{{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} | {{ release.source }} |
SmallCapRelations is part of the IBN (InvestorBrandNetwork).